Background Effective medication is limited for the relief of intermittent claudication, a common manifestation of arterial occlusive disease. Cilostazol is a potent inhibitor of platelet aggregation with vasodilation effects. Objective To evaluate the safety and efficacy of cilostazol for the treatm...
No comments yet
Be the first to share your thoughts!